EA201792095A1 - Производные 2-гомопиперазин-1-ил-4h-1,3-бензотиазин-4-она и способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она - Google Patents

Производные 2-гомопиперазин-1-ил-4h-1,3-бензотиазин-4-она и способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она

Info

Publication number
EA201792095A1
EA201792095A1 EA201792095A EA201792095A EA201792095A1 EA 201792095 A1 EA201792095 A1 EA 201792095A1 EA 201792095 A EA201792095 A EA 201792095A EA 201792095 A EA201792095 A EA 201792095A EA 201792095 A1 EA201792095 A1 EA 201792095A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzothiazin
homopiperazin
hydrochlorides
homo
derivatives
Prior art date
Application number
EA201792095A
Other languages
English (en)
Other versions
EA035946B1 (ru
Inventor
Коул Стюарт
Вадим Альбертович Макаров
Original Assignee
Эколь Политекник Федераль Де Лозанн (Эпфл)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эколь Политекник Федераль Де Лозанн (Эпфл) filed Critical Эколь Политекник Федераль Де Лозанн (Эпфл)
Publication of EA201792095A1 publication Critical patent/EA201792095A1/ru
Publication of EA035946B1 publication Critical patent/EA035946B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Предоставлены производные 2-гомопиперазин-1-ил-4Н-1,3-бензотиазин-4-она формулы (I). Они пригодны при лечении бактериальных инфекций, в частности туберкулеза, язвы Бурули и лепры. Также предоставлен способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она.
EA201792095A 2015-03-23 2016-03-23 Способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она EA035946B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15160267.9A EP3072889A1 (en) 2015-03-23 2015-03-23 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides
PCT/EP2016/056371 WO2016151011A1 (en) 2015-03-23 2016-03-23 2-homopiperazine-1-yl-4h-1,3-benzothiazine-4-one derivatives and process for the preparation of 2- (homo)piperazine 1,3-benzothiazine-4-one hydrochlorides

Publications (2)

Publication Number Publication Date
EA201792095A1 true EA201792095A1 (ru) 2018-03-30
EA035946B1 EA035946B1 (ru) 2020-09-04

Family

ID=52780412

Family Applications (2)

Application Number Title Priority Date Filing Date
EA202091353A EA202091353A1 (ru) 2015-03-23 2016-03-23 Производные 2-гомопиперазин-1-ил-4h-1,3-бензотиазин-4-она и способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она
EA201792095A EA035946B1 (ru) 2015-03-23 2016-03-23 Способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA202091353A EA202091353A1 (ru) 2015-03-23 2016-03-23 Производные 2-гомопиперазин-1-ил-4h-1,3-бензотиазин-4-она и способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она

Country Status (10)

Country Link
US (2) US10160754B2 (ru)
EP (3) EP3072889A1 (ru)
CN (1) CN107567439B (ru)
CA (1) CA2980653A1 (ru)
EA (2) EA202091353A1 (ru)
ES (1) ES2905453T3 (ru)
GE (2) GEP20207127B (ru)
PL (1) PL3274339T3 (ru)
UA (1) UA123724C2 (ru)
WO (1) WO2016151011A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3072889A1 (en) 2015-03-23 2016-09-28 Ecole Polytechnique Federale De Lausanne (Epfl) 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides
CN108929329B (zh) * 2017-05-24 2020-12-11 中国医学科学院药物研究所 2-氮杂环-5-三氟甲基-8-硝基苯并(硫代)吡喃-4-酮类化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101472922B (zh) 2006-05-24 2012-05-30 e.V.汉斯-诺尔-研究院（HKI）莱布尼茨天然产物研究和感染生物学研究所 苯并噻嗪酮衍生物及其作为抗菌剂的应用
WO2009001063A1 (en) 2007-06-22 2008-12-31 Cadbury Holdings Limited Chocolate composition
EP2020406A1 (en) * 2007-07-16 2009-02-04 Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut New antimicrobial compounds, their synthesis and their use for treatment of mammalian infection
LT2640712T (lt) * 2010-11-19 2018-11-12 Ecole polytechnique fédérale de Lausanne (EPFL) 2-piperazin-1-il-4h-1,3-benzotiazin-4-ono dariniai ir jų panaudojimas žinduolių infekcijoms gydyti
EP2468746A1 (en) * 2010-12-23 2012-06-27 The University of Queensland Benzothiazinone compounds and their use as anti-tuberculosis agents
CN103508980B (zh) * 2012-06-14 2016-07-06 四川大学 苯并噻嗪-4-酮衍生物及其制备方法和用途
EP3072889A1 (en) 2015-03-23 2016-09-28 Ecole Polytechnique Federale De Lausanne (Epfl) 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides
CN105669664B (zh) * 2016-02-19 2019-05-10 浙江司太立制药股份有限公司 含有碱性氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法

Also Published As

Publication number Publication date
EP3274339A1 (en) 2018-01-31
EP3919480A1 (en) 2021-12-08
WO2016151011A1 (en) 2016-09-29
CN107567439B (zh) 2021-04-16
US20180051016A1 (en) 2018-02-22
US10160754B2 (en) 2018-12-25
EP3274339B1 (en) 2021-10-13
EP3072889A1 (en) 2016-09-28
GEP20217258B (en) 2021-05-25
CN107567439A (zh) 2018-01-09
ES2905453T3 (es) 2022-04-08
EA035946B1 (ru) 2020-09-04
UA123724C2 (uk) 2021-05-26
US10358442B2 (en) 2019-07-23
CA2980653A1 (en) 2016-09-29
EA202091353A1 (ru) 2020-08-19
US20190077798A1 (en) 2019-03-14
GEP20207127B (en) 2020-06-25
PL3274339T3 (pl) 2022-03-07

Similar Documents

Publication Publication Date Title
CY1124187T1 (el) Ετεροκυκλικα αμιδια ως αναστολεις κινασης
EA201892128A1 (ru) Гетероциклические амиды, полезные в качестве модуляторов
CY1120306T1 (el) Αναστολεις πρωτεϊνικων kinασων
EA201991697A1 (ru) Сульфоксиминовые ингибиторы гликозидазы
CY1120029T1 (el) Παραγωγα 6-(5-υδροξυ-1η-πυραζολ-1-υλ) νικοτιναμιδιου και χρηση τους ως αναστολεις phd
CY1122805T1 (el) Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων
EA201592212A8 (ru) Кристаллические полиморфные формы свободного основания 2-гидрокси-6-((2-(1-изопропил-1н-пиразол-5-ил)пиридин-3-ил)метокси)бензальдегида
EA201591506A1 (ru) Гетероциклические амины в качестве ингибиторов киназы
UY37487A (es) Amidas heterocíclicas como inhibidores de quinasa
MX2021000189A (es) Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias.
BR112021017646A2 (pt) Compostos de azol-amida ativos em termos pesticidas
BR112018001017A2 (pt) inibidores do receptor de fator-1 de estimulação de colônia (csf-1r)
DK3790927T3 (da) Fremgangsmåde, indretning og anvendelse til oparbejdning af i det væsentlige polyalkylenterephthalat
TW201613913A (en) Method of producing thiamethoxam
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
EA201690227A1 (ru) Азаиндольные соединения, их получение и способы их применения
EA202090933A1 (ru) Способ получения гербицидных соединений пиридазинона
MX2017011392A (es) P-toluensulfonato para inhibidor de mek cinasa, y su forma de cristal y su metodo de preparacion.
EA201792095A1 (ru) Производные 2-гомопиперазин-1-ил-4h-1,3-бензотиазин-4-она и способ получения гидрохлоридов 2-(гомо)пиперазин-1,3-бензотиазин-4-она
EA201892449A1 (ru) Конденсированные гетероциклические соединения
DE602007011324D1 (de) Verfahren zur herstellung von 2-substituierten 5-(1-alkylthio)alkylpyridinen
MX367267B (es) Proceso para preparar 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3h -imidazo[4,5-b]piridin-2-il)piridin-2-amina.
MX2020004388A (es) Forma cristalina del inhibidor de alquinil piridina prolil hdroxilasa y metodo para preparar la misma.
PL414935A1 (pl) Sposób otrzymywania 6-acetamidoflawonu
PL414934A1 (pl) Sposób otrzymywania 6-acetamidoflawonu